NewAmsterdam Pharma Company N.V. (NAMS)
NASDAQ: NAMS · Real-Time Price · USD
30.03
+0.02 (0.07%)
Mar 24, 2026, 2:04 PM EDT - Market open
NAMS Market Cap
NAMS has a market cap or net worth of $3.45 billion as of March 24, 2026. Its market cap has increased by 32.10% in one year.
Market Cap
3.45B
Enterprise Value
2.72B
1-Year Change
32.10%
Ranking
Category
Stock Price
$30.03
Market Cap Chart
Since February 8, 2021, NAMS's market cap has increased from $154.45M to $3.45B, an increase of 2,135.50%. That is a compound annual growth rate of 83.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 3.45B | -13.26% |
| Dec 31, 2025 | 3.98B | 44.58% |
| Dec 31, 2024 | 2.75B | 199.19% |
| Dec 29, 2023 | 919.56M | 3.44% |
| Dec 30, 2022 | 889.00M | 537.58% |
| Dec 31, 2021 | 139.43M | -9.72% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 3.63B |
| ACADIA Pharmaceuticals | 3.58B |
| Corcept Therapeutics | 3.58B |
| Dianthus Therapeutics | 3.53B |
| Centessa Pharmaceuticals | 3.49B |
| Structure Therapeutics | 3.48B |
| Spyre Therapeutics | 3.36B |
| Denali Therapeutics | 3.34B |